"Insulin Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Descriptor ID |
D007333
|
| MeSH Number(s) |
C18.452.394.968.500 G07.690.773.984.617
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Resistance".
Below are MeSH descriptors whose meaning is more specific than "Insulin Resistance".
This graph shows the total number of publications written about "Insulin Resistance" by people in this website by year, and whether "Insulin Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 5 | 0 | 5 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 4 | 0 | 4 |
| 2002 | 3 | 5 | 8 |
| 2003 | 3 | 1 | 4 |
| 2004 | 8 | 6 | 14 |
| 2005 | 7 | 4 | 11 |
| 2006 | 5 | 11 | 16 |
| 2007 | 6 | 9 | 15 |
| 2008 | 7 | 6 | 13 |
| 2009 | 5 | 7 | 12 |
| 2010 | 10 | 10 | 20 |
| 2011 | 21 | 13 | 34 |
| 2012 | 21 | 19 | 40 |
| 2013 | 9 | 10 | 19 |
| 2014 | 8 | 13 | 21 |
| 2015 | 11 | 14 | 25 |
| 2016 | 13 | 17 | 30 |
| 2017 | 11 | 15 | 26 |
| 2018 | 9 | 13 | 22 |
| 2019 | 4 | 13 | 17 |
| 2020 | 20 | 11 | 31 |
| 2021 | 13 | 9 | 22 |
| 2022 | 25 | 2 | 27 |
| 2023 | 11 | 0 | 11 |
| 2024 | 8 | 2 | 10 |
| 2025 | 4 | 8 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Resistance" by people in Profiles.
-
Association of genetic scores related to insulin resistance with neurological outcomes in ancestrally diverse cohorts from the Trans-Omics for Precision Medicine (TOPMed) program. Commun Biol. 2025 Sep 24; 8(1):1352.
-
Menopause factors and alterations in gut microbiota and insulin homeostasis: A cross-sectional analysis of the microbiome and insulin longitudinal evaluation study (MILES). Diabetes Obes Metab. 2025 Oct; 27(10):5444-5454.
-
The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes. 2025 Jul 01; 74(7):1196-1204.
-
FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression. Cell Metab. 2025 Jul 01; 37(7):1547-1567.e6.
-
The microRNA miR-30a blocks adipose tissue fibrosis accumulation in obesity. J Clin Invest. 2025 Aug 01; 135(15).
-
Metabolic clearance rate of insulin across the glucose tolerance spectrum by race and ethnicity in youth with obesity. Obesity (Silver Spring). 2025 Jul; 33(7):1365-1374.
-
Persistent Hyperglycemia and Insulin Resistance With the Risk of Worsening Cardiac Damage in Adolescents: A 7-Year Longitudinal Study of the ALSPAC Birth Cohort. Diabetes Care. 2025 Jun 01; 48(6):896-904.
-
PREGNANCY DISORDERS AND MATERNAL CONSEQUENCES: Maternal pre-pregnancy risks and postpartum consequences of gestational diabetes. Reproduction. 2025 Jun 01; 169(6).
-
Effect of aerobic or resistance exercise, or both on insulin secretion, ciliary neurotrophic factor, and insulin-like growth factor-1 in dieting older adults with obesity. Clin Nutr. 2025 Aug; 51:50-62.
-
Muscle metabolic resilience and enhanced exercise adaptation by Esr1-induced remodeling of mitochondrial cristae-nucleoid architecture in males. Cell Rep Med. 2025 May 20; 6(5):102116.